|
|
|
|
|
|
|
ReShape Lifesciences Inc. (RSLS)
|
|
0.0399 -0.001 (-1.48%)
|
09-21 10:36
|
|
Open:
|
0.045
|
Pre. Close:
|
0.0405
|
|
High:
|
0.045
|
Low:
|
0.0385
|
|
Volume:
|
440,915
|
Market Cap:
|
2M
|
|
|
|
Stock Price Prediction (Update at 5:00pm est.)
|
|
If
tomorrow:
|
Open
lower
|
Open
higher
|
|
High:
|
0.04 - 0.04
|
0.04 - 0.04
|
|
Low:
|
0.039 - 0.04
|
0.04 - 0.04
|
|
Close:
|
0.04 - 0.04
|
0.04 - 0.04
|
|
|
|
Technical analysis (as of: 2018-09-21 10:08:42 AM)
|
|
Overall:
|
 
|
|
Stoxline posted a BUY today, upgraded from lower rating. This stock seems to be ready for a new bullish move. If you bought, continue to hold stock until SELL signal. You are relatively safe to buy now, a new upward move is expected.
|
|
Target:
|
Six months: 0.08  One year: 0.09
|
|
Support:
|
Support1: 0.04 Support2: 0.03
|
|
Resistance:
|
Resistance1:
0.06 Resistance2: 0.08
|
|
Pivot:
|
0.06
|
|
Moving Averages:
|
MA(5): 0.04 MA(20): 0.06
MA(100): 2.26 MA(250): 14.03
|
|
MACD:
|
MACD(12,26):
-0.12 Signal(12,26,9): -0.16
|
|
%K %D:
|
%K(14,3): 1.58 %D(3): 0.53
|
|
RSI:
|
RSI(14): 15.34
|
|
52-Week:
|
High: 39
Low: 0.0385 Change(%): -99.9
|
|
Average Vol(K):
|
3-Month: 572406
10-Days 519111
|
|
|
|
|
|
★
Strong Sell
★★
Sell ★★★
Neutral
★★★★
Buy
★★★★★
Strong Buy
|
|
|
Price, moving averages and
Bollinger Bands
|
|
Price and moving averages has closed below its Short term moving average. Short term moving average is currently below mid-term; AND below long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BEARISH in short-term; and BEARISH in mid-long term.RSLS has closed above bottom band by 16.4%. Bollinger Bands are 97.6% narrower than normal. The narrow width of the bands suggests low volatility as compared to RSLS's normal range. The bands have been in this narrow range for 76 bars. This is a sign that the market may be about to initiate a new trend.
|
|
|
Headline News
|
|
2018-08-16T15:23:06-04:00
ReShape Lifesciences Inc. (RSLS) CEO Dan Gladney on Q2 2018 Results - Earnings Call Transcript
2018-08-16T09:24:51-04:00
ReShape Lifesciences: It Can (And Will) Get Much Worse Than This!
|
|
|
Financial Analysis
|
|
Growth
|
|
|
Growth measures the growth of both a company's revenue
and net income. it tells investors how fast a company is growing.
|
|
Profitability
|
|
|
Profitability measures a company’s ability to
generate earnings as compared to its expenses
and other relevant costs.
|
|
Solvency
|
|
|
Solvency measures a company's ability to meet its long-term debts.
Acceptable solvency ratios will vary from industry to industry.
|
|
Efficiency
|
|
|
Efficiency measures the strength of a company's return on invested capital.
It can identify business that are better managed or not.
|
|
Click here to get more fundamental analysis.
|
|
